home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 17, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 462 active entries

Noble Life Sciences

PO Box 242
Woodbine, 21797
United States of America, Maryland
Toll free: 800.864.1839

Phone: 410.795.2222
Fax: 410.795.2222

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Noble Life Sciences is a contract research organization (CRO) that provides a full continuum of preclinical drug, vaccine and medical device development services, from initial product discovery to GLP-compliant studies. Noble state- of- the art facilities are located in Sykesville, MD in the BioHealth Capital Region. Our services are designed to help you get from concept to clinic faster and more efficiently.

The company offers integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care. We have expertise in Infectious Disease, Oncology and Vaccine Development.

Noble's vivarium services group is ready to support your in vivo R&D: housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development. The company also offers custom antibody production services, as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services, we are committed to providing a strong scientific foundation for your preclinical decisions. Noble’s key advantage is the deep expertise and years of experience of the company’s scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. 

With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process

We are licensed by the USDA as an animal research facility, fully accredited by AAALAC, have on file an "Assurance of Compliance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals" and are licensed to use radioactive materials and "Schedule 2 through Schedule 5" controlled substances. In addition to our services, we have a small unique line of monoclonal antibodies to rabbit antigens for sale. We can also provide MHC homozygous matched rabbits and rabbits carrying a human CD4 transgene for use at your facility or ours.


Selected Categories:
Product Company   Service Company
- Research
- Strategic
- Research
- Services

Last update of this entry: September 29, 2020

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.